Science | ABNewswire

Lyme Disease Market is Projected to Boom by 2036 Owing to the Launch of Novel Therapies | DelveInsight

The market dynamics for Lyme Disease is witnessing steady growth driven by the increasing incidence of tick-borne infections, expanding geographic distribution of disease-carrying ticks, growing awareness of early diagnosis and treatment, and the development of innovative prophylactic and therapeutic approaches. … Continue reading →

Gastric Cancer Pipeline Appears Robust With 200+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s “Gastric Cancer Pipeline Insight 2026” report provides comprehensive insights about 200+ companies and 220+ pipeline drugs in the Gastric Cancer pipeline landscape. It covers the Gastric Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Non Small Cell Lung Cancer Pipeline Appears Robust With 100+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s “NSCLC Pipeline Insight 2026” report provides comprehensive insights about 100+ companies and 120+ pipeline drugs in the NSCLC pipeline landscape. It covers the NSCLC pipeline drug profiles, including clinical and nonclinical stage products. It also covers the NSCLC pipeline … Continue reading →

Osteoporosis Pipeline Expands as 30+ Companies Advance Innovative Bone Health Therapies, Finds DelveInsight

There are 30+ key companies, including Alvotech, Transcenta Holding, GlycoNex, and others, developing therapies for Osteoporosis across multiple stages of clinical development. The competitive landscape is characterized by a focus on novel monoclonal antibodies, biosimilars, and small molecules aimed at … Continue reading →

Data Analysis Finds That 7.4 Million ER Diagnostic Errors Occur Annually in the U.S.

New analysis identifies which conditions are most often missed and which cause the most serious harm when they are. A new data analysis from Morris Wilson Knepp Jacquette, P.C., produced in partnership with 1Point21 Interactive, finds that an estimated 7.4 … Continue reading →

Small Lymphocytic Lymphoma Pipeline Gains Momentum: 80+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Small Lymphocytic Lymphoma Pipeline Insight, 2026” report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in Small Lymphocytic Lymphoma pipeline landscape. It covers the Small Lymphocytic Lymphoma pipeline drug profiles, including clinical and non-clinical stage products. It … Continue reading →

Knee Osteoarthritis Pipeline Gains Momentum: 55+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Knee Osteoarthritis Pipeline Insight 2026” report provides comprehensive insights about 55+ companies and 65+ pipeline drugs in the Knee Osteoarthritis pipeline landscape. It covers the Knee Osteoarthritis Pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Muscle-Invasive Bladder Cancer Pipeline Gains Momentum: 10+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Muscle Invasive Bladder Cancer Pipeline Insight 2026” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in the Muscle Invasive Bladder Cancer pipeline landscape. It covers the Muscle Invasive Bladder Cancer pipeline drug profiles, including clinical and … Continue reading →

Thyroid Cancer Pipeline Gains Momentum: 45+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Thyroid Cancer Pipeline Insight 2026” report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Thyroid Cancer pipeline landscape. It covers the Thyroid Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Cutaneous Squamous Cell Carcinoma Pipeline Gains Momentum: 45+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s, “Cutaneous Squamous Cell Carcinoma Pipeline Insight 2026” report provides comprehensive insights about 45+ companies and 45+ pipeline drugs in Cutaneous Squamous Cell Carcinoma pipeline landscape. It covers the Cutaneous Squamous Cell Carcinoma pipeline drug profiles, including clinical and nonclinical … Continue reading →

Monday - July 06, 2026

Category Archives: Science